This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Yogy Simanjuntak: Innovator in Pharmaceutical Compounds
Introduction
Yogy Simanjuntak is a notable inventor based in Yogyakarta, Indonesia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific protein kinases. His work is essential in advancing treatments for various diseases.
Latest Patents
Yogy holds a patent for "Compounds to inhibit calcium/calmodulin dependent protein kinase II and applications thereof." This patent includes novel benzenesulfonamide compounds that inhibit calcium/calmodulin-dependent protein kinase II (CaMKII). The pharmaceutical compositions containing these compounds are designed to treat diseases associated with CaMKII activity, such as flavivirus infections. He has 1 patent to his name.
Career Highlights
Yogy Simanjuntak is affiliated with Academia Sinica, where he conducts research and develops innovative pharmaceutical solutions. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
Yogy collaborates with esteemed colleagues, including Wen-shan Li and Yi-Ling Lin, to further enhance the research and development of his innovative compounds.
Conclusion
Yogy Simanjuntak's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key figure in medical research. His work continues to pave the way for advancements in treatment options for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile